Observed Signal · Sep 28, 2026 · Funding · Source: Tech.eu (European Tech & Deals) · Impact: 1/5 · Sentiment: Positive
Sofinnova Partners Closes €82M Medtech Fund MD Start IV
European life sciences venture capital firm Sofinnova Partners has closed its fourth medtech fund, Sofinnova MD Start IV, at €82 million. The oversubscribed fund will expand the firm's medtech company-creation strategy across Europe and the US, providing additional capacity to launch new ventures and support them through key development stages. Sofinnova plans to launch six to eight medtech companies through the fund over the next five years. The strategy combines clinical insight, entrepreneurial talent, and operational expertise to develop companies addressing unmet medical needs. The new fund follows Sofinnova MD Start III, a €63 million fund that invested across six companies, which collectively raised more than €140 million in follow-on financing. Notable portfolio companies include LimFlow, acquired by Inari Medical for up to $415 million, and PreCARDIA, acquired by Abiomed.
This is a niche funding announcement in the medtech sector, not directly related to advertising technology, marketing technology, or the digital advertising industry.
Track Real-Time Venture Capital Signals & Market Shifts
Polaris7 autonomous intelligence agents track regulatory filings, primary sources, executive changes, and deal flow 24/7. Create your free Explorer workspace to monitor these entities.
Key Takeaways & Evidence Grounding
- Sofinnova Partners closed Sofinnova MD Start IV fund at €82 million.
- The fund was oversubscribed and will focus on medtech company creation in Europe and the US.
- Sofinnova plans to launch six to eight medtech companies through the fund over five years.
- The previous fund, MD Start III, raised €63 million and its portfolio companies raised over €140 million in follow-on financing.
- Portfolio company LimFlow was acquired by Inari Medical for up to $415 million.
Ontology Mapping & Concepts
Related Market Signals & Shifts
Recent verified developments and strategic activity across this market segment.
Seed Capital closes €130M Fund V for Nordic startups
Copenhagen-based seed investor Seed Capital announced the closing of its fifth fund at €130 million, targeting 15-17 companies with first checks of €3-6 million in FinTech, cybersecurity, resilience, and AI-driven B2B sectors. The fund will expand beyond Denmark into the Nordics, with a strategic focus on Sweden. The firm also announced leadership changes: Christian Brøndum, former CEO of Planday, steps in as Managing Partner, and Geeta Schmidt, former CEO and co-founder of Humio, joins as General Partner. Seed Capital has already made initial investments from Fund V in Fortiv, Moxso, Repodo, and Oplane. The firm plans to evaluate opening a Swedish office to strengthen its close-to-founders approach. Its portfolio includes notable companies like Trustpilot, Flatpay, and Lunar.
DIG Ventures Closes $120M Fund III for European AI Infrastructure Startups
European venture capital firm DIG Ventures, founded by MuleSoft's Ross Mason, has closed its third fund at $120 million (€106 million) to invest in early-stage companies building AI-native enterprise and cloud infrastructure. Backed by institutional LPs including Horsley Bridge, Sofina, Granite, and a leading US university endowment, as well as entrepreneur LPs from Slack, Datadog, Nord Security, Cast AI, Supercell, and Dash0, the fund will back approximately 30 European pre-seed and seed-stage companies focusing on AI control points such as data, identity, compliance, and orchestration. The firm aims to lead most rounds and leverage its operational experience to support portfolio companies with go-to-market strategies and US expansion. Notable Fund II portfolio companies include Dash0, which achieved unicorn status after a $110 million Series B, and Taktile, which raised a $110 million Series C led by Goldman Sachs.
Claret Capital closes €575M growth debt fund for European innovators
Claret Capital Partners, a London-based growth debt fund manager, has closed its fourth European Growth Capital Fund at €575 million, exceeding its €500 million target. The fund comprises €440 million in commitments and €135 million in an affiliated discretionary mandate. It will provide growth debt financing to technology, life sciences, and impact-focused companies across Europe. Fund IV is already 32% deployed across 27+ companies, including Billie, Cinclus Pharma, PRODA, Inventiva, and Surfe. The fund attracted commitments from institutional investors such as pension funds, insurers, family offices, and public institutions, plus private wealth via an ELTIF structure. Claret plans to expand its presence in European innovation hubs, including Paris and Berlin. Since inception, Claret has raised €1.3 billion and invested over €1.5 billion across 210+ companies.
Track Real-Time Market Signals & Shifts
Set up custom watchlists to receive automated, evidence-grounded executive digests whenever material signals or shifts occur across your tracked landscape.